Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidharth Mehan

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Neurochemical Research|June 2, 2021
Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALSElizabeth Minj, Shubham Upadhayay, Sidharth Mehan
Current Drug Targets|October 21, 2020
Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic AutismAarti Tiwari, Saloni Rahi, Sidharth Mehan
Neuropeptides|February 27, 2026
Oxytocin beyond social bonding: Advancing neuromodulation, synaptic plasticity, and epigenetic precision in CNS disordersSupratim Paul, Janvi Verma, Sidharth Mehan
Molecular and Cellular Biochemistry|January 3, 2021
Involvement of adenylate cyclase/cAMP/CREB and SOX9/MITF in melanogenesis to prevent vitiligoNavneet Arora, Ehraz Mehmood Siddiqui, Sidharth Mehan
CNS & Neurological Disorders Drug Targets|February 9, 2021
Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological DisordersRajeshwar Kumar Yadav, Elizabeth Minz, Sidharth Mehan
International Immunopharmacology|April 29, 2026
Raloxifene Beyond Osteoporosis: Unlocking Neurorestoration Through Remyelination, Inflammatory Regulation, and Neuroimmune Modulation in CNS PathologiesChandrayee Banerjee, Rohit Kumar Singh, Sidharth Mehan
Endocrine, Metabolic & Immune Disorders Drug Targets|October 24, 2025
Exploring the Influence of Demographic and Clinical Parameters on Knowledge, Attitudes, and Practices in Type-II Diabetes Mellitus Patients in Punjab, India: A Cross-Sectional StudySandeep Kaur, Sidharth Mehan, Ghanshyam Das Gupta
Journal of Molecular Medicine (Berlin, Germany)|December 8, 2022
Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctionsSumit Kumar, Sidharth Mehan, Acharan S Narula
Current Molecular Medicine|January 12, 2021
Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological DisordersElizabeth Minj, Rajeshwar Kumar Yadav, Sidharth Mehan
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 4, 2025
Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: Neuroprotection through IGF-1 and GLP-1 level restorationZuber Khan, Sidharth Mehan, Ghanshyam Das Gupta
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Neurochemical Research|June 2, 2021
Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALSElizabeth Minj, Shubham Upadhayay, Sidharth Mehan
Current Drug Targets|October 21, 2020
Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic AutismAarti Tiwari, Saloni Rahi, Sidharth Mehan
Neuropeptides|February 27, 2026
Oxytocin beyond social bonding: Advancing neuromodulation, synaptic plasticity, and epigenetic precision in CNS disordersSupratim Paul, Janvi Verma, Sidharth Mehan
Molecular and Cellular Biochemistry|January 3, 2021
Involvement of adenylate cyclase/cAMP/CREB and SOX9/MITF in melanogenesis to prevent vitiligoNavneet Arora, Ehraz Mehmood Siddiqui, Sidharth Mehan
CNS & Neurological Disorders Drug Targets|February 9, 2021
Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological DisordersRajeshwar Kumar Yadav, Elizabeth Minz, Sidharth Mehan
International Immunopharmacology|April 29, 2026
Raloxifene Beyond Osteoporosis: Unlocking Neurorestoration Through Remyelination, Inflammatory Regulation, and Neuroimmune Modulation in CNS PathologiesChandrayee Banerjee, Rohit Kumar Singh, Sidharth Mehan
Endocrine, Metabolic & Immune Disorders Drug Targets|October 24, 2025
Exploring the Influence of Demographic and Clinical Parameters on Knowledge, Attitudes, and Practices in Type-II Diabetes Mellitus Patients in Punjab, India: A Cross-Sectional StudySandeep Kaur, Sidharth Mehan, Ghanshyam Das Gupta
Journal of Molecular Medicine (Berlin, Germany)|December 8, 2022
Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctionsSumit Kumar, Sidharth Mehan, Acharan S Narula
Current Molecular Medicine|January 12, 2021
Targeting Abnormal Nrf2/HO-1 Signaling in Amyotrophic Lateral Sclerosis: Current Insights on Drug Targets and Influences on Neurological DisordersElizabeth Minj, Rajeshwar Kumar Yadav, Sidharth Mehan
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 4, 2025
Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: Neuroprotection through IGF-1 and GLP-1 level restorationZuber Khan, Sidharth Mehan, Ghanshyam Das Gupta
Pageof 13